In this study, we investigated a population-based unselected series of Brunei breast cancer patients to determine the prevalence and spectrum of BRCA1 and BRCA2 mutations using Sanger and next-generation sequencing methods and assess the association of pathogenic variants only with sociodemographic, clinicopathological, and family history characteristics of the population. The gene discussed is BRCA2; the disease is breast cancer.